Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment

Neurobiology of Aging

Volumn 35, Issue 1, 2014, Pages 254-260

  Park, Jae Hyun ^a   Seo, Sang Won ^a   Kim, Changsoo ^b   Kim, Sook Hui ^c   Kim, Geon Ha ^d   Kim, Sung Tae ^a   Jeon, Seun ^e   Lee, Jong Min ^e   Oh, Seung Jun ^f   Kim, Jae Seung ^f   Choe, Yearn Seong ^a   Lee, Kyung Han ^a   Shin, Ji Soo ^g   Kim, Chi Hun ^h   Noh, Young ⁱ   Cho, Hanna ^a   Yoon, Cindy W ^j   Kim, Hee Jin ^a   Ye, Byoung Seok ^a   Ewers, Michael ^k   Weiner, Michael W ^l,m   Lee, Jae Hong ^f   Werring, David J ⁿ   Na, Duk L ^a   more..

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Konkuk University Hospital   (South Korea)

^d Mokdong Hospital   (South Korea)

^e Hanyang University   (South Korea)

^f University of Ulsan College of Medicine   (South Korea)

^g Pfizer Korea   (South Korea)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ Gachon University College of Medicine   (South Korea)

^j Inha University School of Medicine   (South Korea)

^k LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁿ UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Amyloid; Cerebrovascular disease; Cognition; Lacune; Microbleed; Pittsburgh compound B; White matter hyperintensity

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B;

AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WHITE MATTER INJURY;

AMYLOID; CEREBROVASCULAR DISEASE; COGNITION; LACUNE; MICROBLEED; PITTSBURGH COMPOUND B; WHITE MATTER HYPERINTENSITY;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; ANILINE COMPOUNDS; BRAIN; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; THIAZOLES;

EID: 84885188433     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.06.026     Document Type: Article

References (45)

1. Ahn H.J., Chin J., Park A., Lee B.H., Suh M.K., Seo S.W., Na D.L. Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J.Korean Med. Sci. 2010, 25:1071-1076.
2. Ahn H.J., Seo S.W., Chin J., Suh M.K., Lee B.H., Kim S.T., Im K., Lee J.M., Lee J.H., Heilman K.M., Na D.L. The cortical neuroanatomy of neuropsychological deficits in mild cognitive impairment and Alzheimer's disease: a surface-based morphometric analysis. Neuropsychologia 2011, 49:3931-3945.
3. Au R., Massaro J.M., Wolf P.A., Young M.E., Beiser A., Seshadri S., D'Agostino R.B., DeCarli C. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch. Neurol. 2006, 63:246-250.
4. Benisty S., Gouw A.A., Porcher R., Madureira S., Hernandez K., Poggesi A., van der Flier W.M., Van Straaten E.C., Verdelho A., Ferro J., Pantoni L., Inzitari D., Barkhof F., Fazekas F., Chabriat H. Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study. J.Neurol. Neurosurg. Psychiatry 2009, 80:478-483.
5. Brun A., Englund E. Awhite matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann. Neurol. 1986, 19:253-262.
6. Carey C.L., Kramer J.H., Josephson S.A., Mungas D., Reed B.R., Schuff N., Weiner M.W., Chui H.C. Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke 2008, 39:397-402.
7. Carmichael O., Schwarz C., Drucker D., Fletcher E., Harvey D., Beckett L., Jack C.R., Weiner M., DeCarli C., Alzheimer's Disease Neuroimaging Initiative Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch. Neurol. 2010, 67:1370-1378.
8. Choi B.R., Lee S.R., Han J.S., Woo S.K., Kim K.M., Choi D.H., Kwon K.J., Han S.H., Shin C.Y., Lee J., Chung C.S., Kim H.Y. Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model. Stroke 2011, 42:2595-2604.
9. Chui H.C., Zarow C., Mack W.J., Ellis W.G., Zheng L., Jagust W.J., Mungas D., Reed B.R., Kramer J.H., Decarli C.C., Weiner M.W., Vinters H.V. Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann. Neurol. 2006, 60:677-687.
10. Cummings J.L. Frontal-subcortical circuits and human behavior. Arch. Neurol. 1993, 50:873-880.
11. Duering M., Zieren N., Herve D., Jouvent E., Reyes S., Peters N., Pachai C., Opherk C., Chabriat H., Dichgans M. Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL. Brain 2011, 134:2366-2375.
12. Goodkin D.E., Rooney W.D., Sloan R., Bacchetti P., Gee L., Vermathen M., Waubant E., Abundo M., Majumdar S., Nelson S., Weiner M.W. Aserial study of new MS lesions and the white matter from which they arise. Neurology 1998, 51:1689-1697.
13. Greenberg S.M., Vernooij M.W., Cordonnier C., Viswanathan A., Al-Shahi Salman R., Warach S., Launer L.J., Van Buchem M.A., Breteler M.M. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009, 8:165-174.
14. Gurol M.E., Viswanathan A., Gidicsin C., Hedden T., Martinez-Ramirez S., Dumas A., Vashkevich A., Ayres A.M., Auriel E., van Etten E., Becker A., Carmasin J., Schwab K., Rosand J., Johnson K.A., Greenberg S.M. Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann. Neurol. 2013, 73:529-536.
15. Hedden T., Mormino E.C., Amariglio R.E., Younger A.P., Schultz A.P., Becker J.A., Buckner R.L., Johnson K.A., Sperling R.A., Rentz D.M. Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults. J.Neurosci. 2012, 32:16233-16242.
16. Hedden T., Van Dijk K.R., Shire E.H., Sperling R.A., Johnson K.A., Buckner R.L. Failure to modulate attentional control in advanced aging linked to white matter pathology. Cereb. Cortex 2012, 22:1038-1051.
17. Hedden T., Oh H., Younger A.P., Patel T.A. Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology 2013, 80:1341-1348.
18. Hiltunen M., Makinen P., Peraniemi S., Sivenius J., van Groen T., Soininen H., Jolkkonen J. Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamus. Neurobiol. Dis. 2009, 35:103-113.
19. Jablonski M., Maciejewski R., Januszewski S., Ulamek M., Pluta R. One year follow up in ischemic brain injury and the role of Alzheimer factors. Physiol. Res. 2011, 60(suppl 1):S113-S119.
20. Jellinger K.A. Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci. 2013, 5:17.
21. Jeon S., Yoon U., Park J.-S., Seo S.W., Kim J.-H., Kim S.T., Kim S.I., Na D.L., Lee J.-M. Fully automated pipeline for quantification and localization of white matter hyperintensity in brain magnetic resonance image. Int. J. Imag. Syst. Tech. 2011, 21:193-200.
22. Jokinen H., Gouw A.A., Madureira S., Ylikoski R., van Straaten E.C., van der Flier W.M., Barkhof F., Scheltens P., Fazekas F., Schmidt R., Verdelho A., Ferro J.M., Pantoni L., Inzitari D., Erkinjuntti T. Incident lacunes influence cognitive decline: the LADIS study. Neurology 2011, 76:1872-1878.
23. Kim H., Na D.L. Normative data on the Korean version of the Boston Naming Test. J.Clin. Exp. Neuropsychol. 1999, 21:127-133.
24. Kim H.J., Kang S.J., Kim C., Kim G.H., Jeon S., Lee J.M., Oh S.J., Kim J.S., Choe Y.S., Lee K.H., Noh Y., Cho H., Yoon C.W., Chin J., Cummings J.L., Lee J.H., Na D.L., Seo S.W. The effects of small vessel disease and amyloid burden on neuropsychiatric symptoms: a study among patients with subcortical vascular cognitive impairments. Neurobiology of Aging 2013, 34:1913-1920.
25. Kim S.H., Park J.S., Ahn H.J., Seo S.W., Lee J.M., Kim S.T., Han S.H., Na D.L. Voxel-based analysis of diffusion tensor imaging in patients with subcortical vascular cognitive impairment: correlates with cognitive and motor deficits. J.Neuroimaging 2011, 21:317-324.
26. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., Bergstrom M., Savitcheva I., Huang G.F., Estrada S., Ausen B., Debnath M.L., Barletta J., Price J.C., Sandell J., Lopresti B.J., Wall A., Koivisto P., Antoni G., Mathis C.A., Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 2004, 55:306-319.
27. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969, 9:179-186.
28. Lee D.Y., Fletcher E., Martinez O., Ortega M., Zozulya N., Kim J., Tran J., Buonocore M., Carmichael O., DeCarli C. Regional pattern of white matter microstructural changes in normal aging, MCI, and AD. Neurology 2009, 73:1722-1728.
29. Lee J.H., Kim S.H., Kim G.H., Seo S.W., Park H.K., Oh S.J., Kim J.S., Cheong H.K., Na D.L. Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B. Neurology 2011, 77:18-25.
30. Marchant N.L., Reed B.R., DeCarli C.S., Madison C.M., Weiner M.W., Chui H.C., Jagust W.J. Cerebrovascular disease, beta-amyloid, and cognition in aging. Neurobiol. Aging 2012, 33:1006.e1025-1006.e1036.
31. Marchant N.L., Reed B.R., Sanossian N., Madison C.M., Kriger S., Dhada R., Mack W.J., Decarli C., Weiner M.W., Mungas D.M., Chui H.C., Jagust W.J. The aging brain and cognition: contribution of vascular injury and abeta to mild cognitive dysfunction. JAMA Neurol. 2013, 70:488-495.
32. Mungas D., Harvey D., Reed B.R., Jagust W.J., DeCarli C., Beckett L., Mack W.J., Kramer J.H., Weiner M.W., Schuff N., Chui H.C. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology 2005, 65:565-571.
33. Nagy Z., Esiri M.M., Jobst K.A., Morris J.H., King E.M., McDonald B., Joachim C., Litchfield S., Barnetson L., Smith A.D. The effects of additional pathology on the cognitive deficit in Alzheimer disease. J.Neuropathol. Exp. Neurol. 1997, 56:165-170.
34. Provenzano F.A., Muraskin J., Tosto G., Narkhede A., Wasserman B.T., Griffith E.Y., Guzman V.A., Meier I.B., Zimmerman M.E., Brickman A.M., Alzheimer's Disease Neuroimaging Initiative White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?. JAMA Neurol. 2013, 70:455-461.
35. Reed B.R., Marchant N.L., Jagust W.J., DeCarli C.C., Mack W., Chui H.C. Coronary risk correlates with cerebral amyloid deposition. Neurobiology of Aging 2012, 33:1979-1987.
36. Reed B.R., Mungas D.M., Kramer J.H., Ellis W., Vinters H.V., Zarow C., Jagust W.J., Chui H.C. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain 2007, 130:731-739.
37. Roman G.C., Erkinjuntti T., Wallin A., Pantoni L., Chui H.C. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002, 1:426-436.
38. Rutten-Jacobs L.C., de Leeuw F.E., Geurts-van Bon L., Gordinou de Gouberville M.C., Schepens-Franke A.N., Dederen P.J., Spliet W.G., Wesseling P., Kiliaan A.J. White matter lesions are not related to beta-amyloid deposition in an autopsy-based study. Curr. Gerontol. Geriatr. Res. 2011, 2011:826862.
39. Schmidt R., Ropele S., Enzinger C., Petrovic K., Smith S., Schmidt H., Matthews P.M., Fazekas F. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann. Neurol. 2005, 58:610-616.
40. Schneider J.A., Wilson R.S., Bienias J.L., Evans D.A., Bennett D.A. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 2004, 62:1148-1155.
41. Seo S.W., Hwa Lee B., Kim E.J., Chin J., Sun Cho Y., Na D.L., Yoon U. Clinical significance of microbleeds in subcortical vascular dementia. Stroke 2007, 38:1949-1951.
42. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997, 277:813-817.
43. Werring D., Frazer D., Coward L., Losseff N., Watt H., Cipolotti L., Brown M., Jager H. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain 2004, 127:2265.
44. Wright C.B., Festa J.R., Paik M.C., Schmiedigen A., Brown T.R., Yoshita M., DeCarli C., Sacco R., Stern Y. White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke 2008, 39:800-805.
45. Zekry D., Duyckaerts C., Moulias R., Belmin J., Geoffre C., Herrmann F., Hauw J.J. Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathol. 2002, 103:481-487.